Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edurne Rujas

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Science Translational Medicine|May 24, 2023
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivoClare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Cell Reports|August 20, 2020
Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane EnvironmentsEdurne Rujas, Sara Insausti, Daniel P Leaman, et al.
Scientific Reports|December 3, 2021
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus diseaseMichael G Sugiyama, Haotian Cui, Dar'ya S Redka, et al.
Nature Communications|June 17, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersEdurne Rujas, Iga Kucharska, Yong Zi Tan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Science Translational Medicine|May 24, 2023
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivoClare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Cell Reports|August 20, 2020
Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane EnvironmentsEdurne Rujas, Sara Insausti, Daniel P Leaman, et al.
Scientific Reports|December 3, 2021
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus diseaseMichael G Sugiyama, Haotian Cui, Dar'ya S Redka, et al.
Nature Communications|June 17, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersEdurne Rujas, Iga Kucharska, Yong Zi Tan, et al.
Pageof 4